The ethyl alcohol extract of Hizikia fusiforme inhibits matrix metalloproteinase activity and regulates tight junction related protein expression in Hep3B human hepatocarcinoma cells

Journal of Medicinal Food
Sung Ok Kim, Yung Hyun Choi

Abstract

We tested the correlation between the tightness of tight junctions (TJs) and the anti-invasive activity of the ethyl alcohol extract of Hizikia fusiforme (EHF) in Hep3B human hepatocarcinoma cells. EHF inhibited cell proliferation, motility, and invasiveness, which were associated with increased TJ tightness, as demonstrated by an increase in transepithelial electrical resistance. EHF dose-dependently decreased the secretion of matrix metalloprotease-2 and -9, which correlated with a decrease in mRNA and protein expression, but increased tissue inhibitor of metalloproteinase-1 and -2 mRNA levels. Additionally, immunoblotting results indicated that EHF suppressed the major components of TJ, claudins (-1, -3, and -4), which play a key role in the control and selectivity of paracellular transport. These data indicate that EHF may inhibit cancer cell invasion through the tightening of TJs, which may counteract the up-regulation of claudins. Furthermore, EHF treatment decreased the expression of insulin-like growth factor-1 receptor proteins, while concurrently increasing that of thrombospondin-1 and E-cadherin. In conclusion, these results suggest that EHF treatment may inhibit tumor metastasis and invasion and therefore act as a d...Continue Reading

References

Feb 24, 2001·Annals of the New York Academy of Sciences·A H GitterM Fromm
Nov 1, 2001·Annual Review of Cell and Developmental Biology·M D Sternlicht, Z Werb
Feb 8, 2002·Japanese Journal of Cancer Research : Gann·S TokudomeM A Moore
May 7, 2002·Nature Reviews. Cancer·Mikala Egeblad, Zena Werb
May 11, 2002·Journal of Cellular and Molecular Medicine·Jack Lawler
Mar 4, 2005·Breast Cancer Research : BCR·Anna-Mária TokésZsuzsa Schaff
Apr 6, 2005·Drug Discovery Today·James M MullinJames J Thornton
Jun 25, 2005·Current Cancer Drug Targets·F MannelloS Papa
Oct 29, 2005·FEBS Letters·Silvia Souza de OliveiraJosé Andrés Morgado-Díaz
Dec 22, 2005·Frontiers in Bioscience : a Journal and Virtual Library·Charles J Malemud
Feb 8, 2006·Annual Review of Physiology·Christina M Van Itallie, James M Anderson
Feb 24, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Steven C CunninghamElizabeth Montgomery
Jul 11, 2006·American Journal of Physiology. Cell Physiology·George M VergheseGeorge H Caughey
Jul 14, 2006·BMC Cancer·Kyle J HewittPatrice J Morin
Nov 21, 2007·Molecular Cancer Therapeutics·Ying Chi IpSheung Tat Fan
Feb 16, 2008·The British Journal of Nutrition·Kim Van DeunFreddy Haesebrouck

❮ Previous
Next ❯

Citations

Aug 10, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Chen ZhangSe-Kwon Kim
Apr 2, 2013·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Chang-Hee KangGi-Young Kim
Sep 23, 2014·Seminars in Cell & Developmental Biology·Tracey A Martin

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
protein assay
electrophoresis

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.